Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.72
(
-0.93%
)
Bitcoin
74,302.49
(
0.49%
)
News Focus
News Focus

Replies to post #149056 on Biotech Values

Replies to #149056 on Biotech Values
icon url

DewDiligence

09/20/12 4:03 PM

#149064 RE: biomaven0 #149056

Not too impressive a pipeline there. Xalkori will likely be supplanted, bosutinib will be a bust. Tofacitinib could be significant though.

You forgot about Eliquis. Even though PFE owns only half of it, Eliquis will likely bring in more sales for PFE than all of the drugs you mentioned combined.
icon url

BTH

09/20/12 6:20 PM

#149069 RE: biomaven0 #149056

What large pharma do you think has the best pipeline? Bristol with their oncology program (the parts the acquired from Medarex), or Roche, or...?